SCHEMBL30734153

SCHEMBL30734153

COc1cc2c(cc1OC)CN(c1ncnc3ccc(Br)cc13)CC2

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 4/20 0.59
ACHE P22303 4/20 0.56
BACE1 P56817 4/20 0.56
ALDH1A1 P00352 2/20 0.53
NPSR1 Q6W5P4 1/20 0.53
PDGFRB P09619 2/20 0.48
KIT P10721 1/20 0.48
PDGFRA P16234 1/20 0.48
FLT3 P36888 1/20 0.48
KMT2A Q03164 2/20 0.47
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
KDM4E B2RXH2 1/20 0.47
MEN1 O00255 1/20 0.47
LMNA P02545 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
HPGD P15428 1/20 0.47
TSHR P16473 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4761451 0.86 ACHE (0.67) ACHEBACE1KITEGFRPDE10A
Hydrochloric Acid SCHEMBL4760523 0.84 ACHE (0.66) ACHEBACE1KITEGFRPDE10A
SCHEMBL30734223 0.80 CYP1A2 (0.48) ACHEBACE1ALDH1A1KMT2ANPC1
SCHEMBL30734140 0.80 CYP1A2 (0.51) ACHEBACE1ALDH1A1KMT2AKDM4E
SCHEMBL4397401 0.80 ACHE (0.59) ACHEBACE1PDGFRBEGFRPDE10A
SCHEMBL4762801 0.79 ACHE (0.62) ACHEBACE1KITEGFRPDE10A
SCHEMBL14407961 0.78 HTR7 (0.68) ACHEBACE1KITEGFRPDE10A
SCHEMBL4406170 0.76 ACHE (0.58) ACHEBACE1PDGFRBKITEGFR
SCHEMBL855634 0.75 ACHE (0.59) ACHEBACE1PDGFRBKITPDGFRA
SCHEMBL4349956 0.75 HTT (1.00) HTTACHEBACE1ALDH1A1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250382301-A1 SMALL MOLECULE INHIBITORS OF DYRK/CLK AND USES THEREOF UNIV ARIZONA (US) 2025-12-18 US disclosed
EP-4543888-A1 SMALL MOLECULE INHIBITORS OF DYRK/CLK AND USES THEREOF Arizona Board of Regents on behalf of The University of Arizona (US) 2025-04-30 EP disclosed
WO-2023250083-A1 SMALL MOLECULE INHIBITORS OF DYRK/CLK AND USES THEREOF ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) 2023-12-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250382301-A1 SMALL MOLECULE INHIBITORS OF DYRK/CLK AND USES THEREOF CLK2, CLK3, CLK1 HTT 713/4885ACHE 3704/4885BACE1 1412/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.